Fixed versus variable dose of prothrombin complex concentrate for counteracting vitamin K antagonist therapy

Transfusion Medicine

Volumn 21, Issue 2, 2011, Pages 116-123

  Khorsand, N ^a   Veeger, N J G M ^b   Muller, M ^a   Overdiek, J W P M ^a   Huisman, W ^a   Van Hest, R M ^c   Meijer, K ^b  

^a MEDICAL CENTER HAAGLANDEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c HAGA HOSPITAL   (Netherlands)

Author keywords

Bleeding; Cofact; Prothrombin complex concentrate; Vitamin K antagonist

Indexed keywords

ANTIVITAMIN K; BLOOD CLOTTING FACTOR 9; COFACT; PHENPROCOUMON; PROTHROMBIN COMPLEX; UNCLASSIFIED DRUG; VITAMIN K GROUP;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL ASSESSMENT; DEMOGRAPHY; DRUG DOSE REGIMEN; DRUG EFFICACY; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPOVOLEMIC SHOCK; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; THROMBOEMBOLISM;

ACENOCOUMAROL; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ANTIDOTES; BLOOD COAGULATION FACTORS; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PHENPROCOUMON; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; VITAMIN K; WARFARIN;

EID: 79951667284     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2010.01050.x     Document Type: Article

References (12)

1. Ansell, J., Hirsh, J. & Hylek, E. (2008) Pharmacology and management of the vitamin K antagonists: American College of Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 133, 160S-198S.
2. Ehrlich, H.J., Henzl, M.J. & Gomperts, E.D. (2002) Safety of factor VIII inhibitor bypass activity (FEIBA): 10-year compilation of thrombotic adverse events. Haemophilia, 8, 83-90.
3. Gadisseur, A.P., van der Meer, F.J., Adriaansen, H.J., Fihn, S.D. & Rosendaal, F.R. (2002) Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon. British Journal of Haematology, 117, 940-946.
4. Lankiewicz, M.W., Hays, J., Friedman, K.D., Tinkoff, G. & Blatt, P.M. (2006) Urgent reversal of warfarin with prothrombin complex concentrate. Journal of Thrombosis and Haemostasis, 4, 967-970.
5. Leendertse, A.J., Egberts, A.C., Stoker, L.J. & van den Bemt, P.M. (2008) Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Archives of Internal Medicine, 168, 1890-1896.
6. Lubetsky, A., Hoffman, R., Zimlichman, R., Eldor, A., Zvi, J., Kostenko, V. & Brenner, B. (2004) Efficacy and safety of a prothrombin complex concentrate (Octaplex®) for rapid reversal of oral anticoagulation. Thrombosis Research, 113, 371-378.
7. Pabinger, I., Brenner, B., Kalina, U., Knaub, S., Nagy, A. & Ostermann, H. (2008) Prothrombin complex concentrate (Beriplex P/N®) for emergency anticoagulation reversal: a prospective multinational clinical trial. Journal of Thrombosis and Haemostasis, 6, 622-631.
8. Palareti, G., Leali, N., Coccheri, S. et al. (1996) Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian study on complications of oral anticoagulant therapy. Lancet, 348, 423-428.
9. Riess, H.B., Meier-Hellmann, A., Motsch, J., Elias, M., Kursten, F.W. & Dempfle, C.E. (2007) Prothrombin complex concentrate (Octaplex®) in patients requiring immediate reversal of oral anticoagulation. Thrombosis Research, 121, 9-16.
10. Schulman, S., Kearon, C. on behalf of the subcommittee on control of anticoagulation of the Scientific and Standardization committee of the International Society on Thrombosis and Haemostasis. (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. Scientific and Standardization Committee Communication. Journal of Thrombosis and Haemostasis, 3, 692-694.
11. Van Aart, L., Eijkhout, H.W., Kamphuis, J.S., Dam, M., Schattenkerk, M.E., Schouten, T.J., Ploeger, B. & Strengers, P.F. (2006) Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial. Thrombosis Research, 118, 313-320.
12. Veeger, N.J., Piersma-Wichers, M., Tijssen, J.G., Hillege, H.L. & van der Meer, J. (2005) Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism. British Journal of Haematology, 128, 513-519.